COMPASS PATHWAYS PLC Increase (Decrease) in Other Operating Assets
COMPASS PATHWAYS PLC (CMPS) reported Increase (Decrease) in Other Operating Assets of $44.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2023-05-11
- COMPASS PATHWAYS PLC increase (decrease) in other operating assets for the quarter ending 2023-03-31 was $44.00K, a 85.85% decline year-over-year.
- COMPASS PATHWAYS PLC increase (decrease) in other operating assets for the quarter ending 2022-12-31 was $1.00K.
- COMPASS PATHWAYS PLC increase (decrease) in other operating assets for the quarter ending 2022-09-30 was -$103.00K, a 156.59% decline year-over-year.
- COMPASS PATHWAYS PLC increase (decrease) in other operating assets for the quarter ending 2022-06-30 was $98.00K.
- COMPASS PATHWAYS PLC increase (decrease) in other operating assets for fiscal 2022 was $307.00K, a 91.88% increase from fiscal 2021.
- COMPASS PATHWAYS PLC increase (decrease) in other operating assets for fiscal 2021 was $160.00K, a 180.70% increase from fiscal 2020.
- COMPASS PATHWAYS PLC increase (decrease) in other operating assets for fiscal 2020 was $57.00K.
- COMPASS PATHWAYS PLC increase (decrease) in other operating assets for fiscal 2019 was $0.00.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2023-03-31 | $44.00K 10-Q · filed 2023-05-11 | $45.00K derived: sum of 2 quarters · filed 2023-05-11 | -$58.00K derived: sum of 3 quarters · filed 2023-05-11 | $40.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$102.00K derived: sum of 2 quarters · filed 2023-02-28 | -$4.00K derived: sum of 3 quarters · filed 2023-02-28 | $307.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | -$103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$5.00K derived: sum of 2 quarters · filed 2022-11-03 | $306.00K 10-Q · filed 2022-11-03 | $298.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-06-30 | $98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $409.00K 10-Q · filed 2022-08-04 | $401.00K derived: sum of 3 quarters · filed 2023-05-11 | $583.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-03-31 | $311.00K 10-Q · filed 2023-05-11 | $303.00K derived: sum of 2 quarters · filed 2023-05-11 | $485.00K derived: sum of 3 quarters · filed 2023-05-11 | $478.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $174.00K derived: sum of 2 quarters · filed 2023-02-28 | $167.00K derived: sum of 3 quarters · filed 2023-02-28 | $160.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $182.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $175.00K derived: sum of 2 quarters · filed 2022-11-03 | $168.00K 10-Q · filed 2022-11-03 | $166.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$14.00K 10-Q · filed 2022-08-04 | -$16.00K derived: sum of 3 quarters · filed 2023-02-28 | -$24.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$7.00K 10-Q · filed 2022-05-10 | -$9.00K derived: sum of 2 quarters · filed 2023-02-28 | -$17.00K derived: sum of 3 quarters · filed 2023-02-28 | |
| 2020-12-31 | -$2.00K derived: 10-K 12 month − 6-K 9 month · filed 2023-02-28 | -$10.00K derived: sum of 2 quarters · filed 2023-02-28 | $57.00K 10-K · filed 2023-02-28 | |
| 2020-09-30 | -$8.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09 | $59.00K 6-K · filed 2021-11-09 | ||
| 2020-06-30 | $67.00K 6-K · filed 2021-08-11 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |